Hit enter to search or ESC to close
Biocellvia
Menu
  • Home
  • Biocellvia
  • Therapeutic Areas
    • Preclinical
    • Clinical
    • Tailor-made assay
  • Publications
  • Contact
Category

NASH / NAFLD

NASH / NAFLD

Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome

NASH / NAFLD

Automated whole slide image analysis for a translational quantification of liver fibrosis

NASH / NAFLD

Best Practices in Liver Biopsy Histologic Assessment for Nonalcoholic Steatohepatitis Clinical Trials: Expert Opinion

Paris Nash 2021NASH / NAFLDPoster

DISTRIBUTION OF LIPID VESICLE SIZE AS POTENTIAL MARKER OF NAS SEVERITY: ASSESSMENT WITH MORPHOQUANT-NASH AND MRI

Paris Nash 2021NASH / NAFLD

Time-efficient and Reliable Automated Liver Fibrosis Quantification in Preclinical Fibrosis Models using WSI

NASH / NAFLDPoster

Follow-up of NAFLD/NASH progression using an automated histological image analysis

NASH / NAFLD

Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis

NASH / NAFLD

Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH

NASH / NAFLD

Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21

  • Home
  • Biocellvia
  • Therapeutic Areas
    • Preclinical
    • Clinical
    • Tailor-made assay
  • Publications
  • Contact

Contact us

Our address :
10 rue Grignan
13001 Marseille, France

Our phone number :
+33 4 91 06 18 26

  • Home
  • Biocellvia
  • Therapeutic Areas
    • Preclinical
    • Clinical
    • Tailor-made assay
  • Publications
  • Contact